Your browser doesn't support javascript.
loading
The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension.
Newnham, Michael; South, Kieron; Bleda, Marta; Auger, William R; Barberà, Joan A; Bogaard, Harm; Bunclark, Katherine; Cannon, John E; Delcroix, Marion; Hadinnapola, Charaka; Howard, Luke S; Jenkins, David; Mayer, Eckhard; Ng, Choo; Rhodes, Christopher J; Screaton, Nicholas; Sheares, Karen; Simpson, Michael A; Southwood, Mark; Su, Li; Taboada, Dolores; Traylor, Matthew; Trembath, Richard C; Villar, Sofia S; Wilkins, Martin R; Wharton, John; Gräf, Stefan; Pepke-Zaba, Joanna; Laffan, Michael; Lane, David A; Morrell, Nicholas W; Toshner, Mark.
Afiliação
  • Newnham M; Dept of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
  • South K; Royal Papworth Hospital, Cambridge, UK.
  • Bleda M; Centre for Haematology, Imperial College London, London, UK.
  • Auger WR; Dept of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
  • Barberà JA; University of California, San Diego, CA, USA.
  • Bogaard H; Hospital Clínic - IDIBAPS-CIBER Enfermedades Respiratorias, University of Barcelona, Barcelona, Spain.
  • Bunclark K; VU University Medical Centre, Amsterdam, The Netherlands.
  • Cannon JE; Royal Papworth Hospital, Cambridge, UK.
  • Delcroix M; Royal Papworth Hospital, Cambridge, UK.
  • Hadinnapola C; KU Leuven - University of Leuven, Leuven, Belgium.
  • Howard LS; Dept of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
  • Jenkins D; Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Mayer E; Royal Papworth Hospital, Cambridge, UK.
  • Ng C; Kerckhoff Heart and Lung Centre, Bad Nauheim, Germany.
  • Rhodes CJ; Royal Papworth Hospital, Cambridge, UK.
  • Screaton N; Centre for Pharmacology and Therapeutics, Dept of Medicine, Hammersmith Campus, Imperial College London, London, UK.
  • Sheares K; Royal Papworth Hospital, Cambridge, UK.
  • Simpson MA; Royal Papworth Hospital, Cambridge, UK.
  • Southwood M; Dept of Medical and Molecular Genetics, King's College London School of Basic and Medical Biosciences, London, UK.
  • Su L; Royal Papworth Hospital, Cambridge, UK.
  • Taboada D; MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
  • Traylor M; Royal Papworth Hospital, Cambridge, UK.
  • Trembath RC; Dept of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
  • Villar SS; Dept of Medical and Molecular Genetics, King's College London School of Basic and Medical Biosciences, London, UK.
  • Wilkins MR; MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
  • Wharton J; Centre for Pharmacology and Therapeutics, Dept of Medicine, Hammersmith Campus, Imperial College London, London, UK.
  • Gräf S; Centre for Pharmacology and Therapeutics, Dept of Medicine, Hammersmith Campus, Imperial College London, London, UK.
  • Pepke-Zaba J; Dept of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
  • Laffan M; Dept of Haematology, National Health Service Blood and Transplant Centre, University of Cambridge, Cambridge, UK.
  • Lane DA; National Institute of Health Research BioResource for Translational Research, Cambridge Biomedical Campus, Cambridge, UK.
  • Morrell NW; Royal Papworth Hospital, Cambridge, UK.
  • Toshner M; Centre for Haematology, Imperial College London, London, UK.
Eur Respir J ; 53(3)2019 03.
Article em En | MEDLINE | ID: mdl-30655285

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Embolia Pulmonar / Fator de von Willebrand / Proteína ADAMTS13 / Hipertensão Pulmonar Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Respir J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Embolia Pulmonar / Fator de von Willebrand / Proteína ADAMTS13 / Hipertensão Pulmonar Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Respir J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido